University Of Notre Dame Du Lac Vanda Pharmaceuticals Inc. Transaction History

University Of Notre Dame Du Lac

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$13.37 - $18.85 $1.72 Million - $2.42 Million	-128,346 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$17.59 - $31.05 $542,211 - $957,116	30,825 Added 31.61%	128,346 $2.36 Million
Q4 2018 Feb 13, 2019	BUY	$18.97 - $31.47 $1.85 Million - $3.07 Million	97,521 New	97,521 $2.55 Million
Q3 2018 Nov 13, 2018	SELL	$18.25 - $23.0 $2.99 Million - $3.76 Million	-163,626 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$13.95 - $19.15 $100,551 - $138,033	-7,208 Reduced 4.22%	163,626 $3.12 Million
Q1 2018 May 15, 2018	SELL	$14.05 - $20.2 $441,113 - $634,199	-31,396 Reduced 15.52%	170,834 $2.88 Million
Q4 2017 Feb 13, 2018	BUY	$12.85 - $18.1 $571,169 - $804,526	44,449 Added 28.17%	202,230 $3.07 Million
Q3 2017 Nov 13, 2017	BUY	$15.4 - $18.85 $2.43 Million - $2.97 Million	157,781	157,781 $2.82 Million

156

45.2M

86.1K

40.8K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $250M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of University Of Notre Dame Du Lac, based on Form 13F filings with the SEC.

Stay updated on University Of Notre Dame Du Lac with notifications on news.